MW EG169 articl NS 20160223171404 captis executive search management consulting leadership board services

ClearPoint Neuro stock price target raised to $38 from $23 at B. Riley

MW EG169 articl NS 20160223171404 captis executive search management consulting leadership board services

ClearPoint Neuro Inc.

Clearpoint Neuro, Inc. engages in the development and commercialization of innovative platforms for performing minimally invasive surgical procedures in the brain and heart. It conducts its procedures under direct, intra-procedural magnetic resonance imaging guidance. Its product platform is comprises of ClearPoint system and ClearTrace system. The company was founded by Paul A. Bottomley on March 12, 1998 and is headquartered in Irvine, CA.

This is not a CAPTIS article. Originally, it was published here.